NCT06098690

Brief Summary

Community members ages 18 - 45 years old from the El Paso, Texas, U.S.-Mexico Border Region will be recruited to compare psychoeducational multimedia interventions focused on the human papillomavirus (HPV). Our hypothesis is that adults who view culturally tailored multimedia stories encouraging HPV vaccination will report higher vaccine uptake rates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 24, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

May 2, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2024

Completed
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

4 months

First QC Date

October 19, 2023

Last Update Submit

April 6, 2026

Conditions

Keywords

Human Papillomavirus VaccinationHuman Papillomavirus Cancer ScreeningHPV Cancer PreventionHPV Cancer MitigationSexual and Reproductive HealthU.S.-Mexico Border HealthBehavioral ResearchCommunity Engaged ResearchHealth DisparitiesHealth InequitiesSocial Determinants of HealthMaleFemaleAdultYoung Adult

Outcome Measures

Primary Outcomes (2)

  • HPV Vaccination Status

    HPV vaccine uptake (yes, no)

    Baseline (pre-assessment), 1 month post-intervention

  • HPV Vaccine Intention Score

    HPV vaccine intention score measured on a Likert scale from 1) Strongly disagree to (5) Strongly agree.

    Baseline (pre-assessment), immediately post-intervention (0 months), 1 month post-intervention.

Secondary Outcomes (2)

  • HPV Vaccine Attitude Score

    Baseline (pre-assessment), immediately post-intervention (0 months), 1 month post-intervention

  • HPV Knowledge Score

    Baseline (pre-assessment), immediately post-intervention (0 months), 1 month post-intervention

Study Arms (2)

Treatment

EXPERIMENTAL

A tailored HPV psychoeducational multimedia intervention

Behavioral: Culturally Tailored Multimedia Psychoeducational HPV Intervention

Active Control

ACTIVE COMPARATOR

General/standard multimedia materials on HPV and HPV vaccine

Behavioral: General HPV Multimedia Psychoeducational Control Group

Interventions

The culturally tailored multimedia psychoeducational intervention will involve audio and visual content and will be delivered in a bilingual fashion (English and Spanish) among adults 18-45 years-old.

Treatment

The general/publicly available multimedia intervention will involve audio and visual content and will be delivered in a bilingual fashion (English and Spanish) among adults 18-45 years-old.

Active Control

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adults between the ages 18 and 45 years old
  • Adults who have not completed the HPV vaccine series (unvaccinated or under-vaccinated)
  • Adults currently living or working in El Paso County, Texas

You may not qualify if:

  • Adults who participated in Phases I or II of the larger research project \[cross-sectional phases\]
  • Adults younger than 18 years of age
  • Adults older than 45 years of age
  • Adults that do not reside, plan to live or work in El Paso County, Texas, within the next 12 months after the start of the intervention
  • Adults who are unable to participate in the full study intervention and follow-up time-points
  • Adults who cannot complete study participation and activities in either the English or Spanish languages.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas at El Paso, Border Biomedical Center

El Paso, Texas, 79968, United States

Location

Related Links

MeSH Terms

Conditions

BehaviorVaccine-Preventable DiseasesPatient ComplianceCoitus

Condition Hierarchy (Ancestors)

InfectionsPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorSexual Behavior

Study Officials

  • Eva M Moya, PhD, LMSW

    The University of Texas at El Paso, Border Biomedical Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
* Participants \[blinding\]: participants will be randomly assigned to treatment and control groups, they will not be made aware of other participant's receipt of treatment or control materials. Participants will be asked not to discuss this project outside of the intervention; delivery of the intervention or other educational materials will be virtual, limiting the ability of participants to interact with one another during the study. * Outcome assessor \[blinding\]: to reduce bias in the implementation and assessment of the clinical trial, participant information and pre-post survey responses will be maintained separately from the assignment and delivery of the intervention.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: A parallel trial design will be used to examine the effectiveness of the Culturally Tailored HPV Psychoeducational Multimedia Community Intervention. Community members who are HPV vaccine naïve or under-vaccinated (given vaccine recommendations) will be randomly assigned to one of two conditions: 1) experimental condition in which they receive the tailored multimedia intervention, and 2) active control condition in which they receive general/standard materials.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

October 19, 2023

First Posted

October 24, 2023

Study Start

May 2, 2024

Primary Completion

August 28, 2024

Study Completion

August 28, 2024

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Collected deidentified individual participant data (IPD), all IPD that underlie results in a publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Approximately, starting 6 months-post scholarly publication of previously listed primary and secondary study outcome(s).
Access Criteria
Collected deidentified IPD and supporting information will be provided on a case by case basis following a formal request to the University of Texas at El Paso (UTEP) Institutional Review Board (IRB) and subsequent approval by the Principal Investigator.
More information

Locations